Logo for Genmab

Genmab Investor Relations Material

Latest events

Logo for Genmab

Status Update

Genmab
Logo for Genmab

Status Update

11 Dec, 2024
Logo for Genmab

Q3 2024

6 Nov, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from Genmab

Access all reports
Segment Data
Access more data
Revenue by
Type
Royalties
Milestone revenue
Reimbursement revenue
Collaboration revenue
License revenue
Expenses by
Financials
Genmab, a biotechnology company, develops antibody therapeutics for the treatment of cancer and other diseases primarily in Europe.